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Q fever is an emerging infectious disease among US 
soldiers serving in Iraq. Three patients have had atypical 
manifestations, including 2 patients with acute cholecystitis 
and 1 patient with acute respiratory distress syndrome. Pro-
viders must be aware of Q fever’s signs and symptoms to 
avoid delays in treatment.
Q 
fever, caused by infection with Coxiella burnettii, is 
an emerging infectious disease among US soldiers 
deployed to Iraq and Afghanistan; >30 cases have been re-
ported (1–3). We describe 3 cases of Q fever in soldiers 
treated from July through December 2006 at Walter Reed 
Army Medical Center (WRAMC). 
The Patients
In December 2006, 1 week after returning from Iraq, a 
22-year-old white male Army National Guard member was 
seen at a New Hampshire hospital, with ﬂ  ulike symptoms, 
pleuritic chest pain, and mild abdominal pain. His initial ex-
amination noted temperature of 38.3°C, leukocytes 3.3×109 
cells/μL (normal 4.5–10.5 × 103 cells/μL), platelets 121×103 
cells/μL (normal 150–450 × 103 cells/μL), aspartate amino-
transferase (AST) 144 IU/L (normal 15–46 IU/L), and ala-
nine aminotransferase (ALT) 154 IU/L (reference 11–66 
IU/L). He was admitted and treated with ceftriaxone and 
azithromycin. Although his fever decreased within 48 h, 
he had persistent abdominal pain, worsening liver func-
tion test results (AST 779, ALT 993, alkaline phosphatase 
269 U/L [reference 38–126 U/L]), and increasing shortness 
of breath. An ultrasound examination of the right upper 
quadrant showed hepatosplenomegaly and a thickened gall 
bladder wall without evidence of cholelithiasis. Despite 
initially normal chest radiographic results, a repeat radio-
graphic examination showed bilateral pulmonary inﬁ  ltrates. 
Ceftriaxone therapy was discontinued, pipercillin/tazobac-
tam therapy was started, and azithromycin was continued. 
General surgery stated that the patient had a nonsurgical 
abdomen. After consultation with WRAMC, the patient 
was given a dose of doxycycline and gentamicin before 
being transferred to a New Hampshire medical center. Blood 
cultures and serologic tests for Epstein Barr virus and cyto-
megalovirus were pending. A computed tomographic (CT) 
examination of the chest, abdomen, and pelvis (Figure, left 
panel) showed gall bladder wall thickening (10 mm) with-
out ductal dilatation, hepatosplenomegaly, and bilateral 
ground glass pulmonary inﬁ  ltrates. Serologic tests were 
negative for hepatitis B and C. Thick and thin smears were 
negative for parasitic disease. Despite the ﬁ  ndings on CT 
scan, the patient began to improve clinically and had reso-
lution of abdominal pain and shortness of breath. He was 
transferred to WRAMC, where he continued to improve. 
Pipercillin/tazobactam was discontinued, but doxycycline 
was continued. A presumptive diagnosis of Q fever was 
made, and he was discharged to complete a 14-day course 
of doxycycline. Serologic tests for C. burnettii were posi-
tive with a phase 2 immunoglobulin M (IgM) titer of 256 
(negative <1:64), phase 2 IgG titer of 128 (negative <16), 
and negative phase 1 serologic results. A month later he felt 
well and had normal liver function test results. No exposure 
factors were identiﬁ  ed.
The second case occurred in December 2006, when a 
previously healthy 24-year-old male Army National Guard 
member was admitted to the 28th Combat Support Hospital 
(CSH) in Baghdad, Iraq, with ﬂ  ulike symptoms, mild nausea, 
and a dry, 10-day cough. At admission, his temperature was 
40.2°C, but his other vital signs were normal. He had mild 
epigastric tenderness to palpation; otherwise, examination 
results were normal. Laboratory results included leukocytes 
3.9×103 cells/μL, platelets of 130×103 cells/μL, alkaline 
phosphatase 104 U/L, AST 824 U/L, ALT 786 U/L, total 
bilirubin 1.2 mg/dL (reference 0.2–1.3 mg/dL), and gamma 
glutamyl transferase (GGT) 97 (reference 12–58). Initial 
erythrocyte sedimentation rate was within normal limits at 
18 mm/hr (reference <20 mm/h). Results of blood cultures, 
monospot, and hepatitis B, C, and HIV screens were nega-
tive. A CT scan showed diffuse enhancement of the gallblad-
der with gallbladder wall thickening (Figure, right panel). A 
small amount of pericholecystic ﬂ  uid was seen, but no dis-
tension of the gallbladder or gallstones were noted. These 
ﬁ  ndings prompted a general surgery evaluation for acute 
cholecystitis, but their examination results were not consis-
tent with this diagnosis. Given the patient’s ﬂ  ulike symp-
toms and laboratory abnormalities, the diagnosis of Q fever 
was considered. The patient had initially been treated with 
doxycycline and metronidazole, but metronidazole was dis-
continued when his physical examination results remained 
benign. His fever curve decreased within 2 days of receiving 
doxycycline. He was transferred out of theater to Landstuhl 
Regional Medical Center in Germany for further evaluation. 
Q fever was conﬁ  rmed with C. burnettii serum titers of 2,048 
for phases 1 and 2 IgM. He improved with doxycycline, 100 
mg twice a day for 14 days, and was subsequently returned 
to duty. No exposure factors were identiﬁ  ed.
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The third case occurred in July 2006 in a 34-year-
old female active duty soldier with a history of asthma. 
She was seen at the troop medical clinic in Baghdad, Iraq, 
with ﬂ  ulike symptoms. She was given symptomatic treat-
ment and released but returned with altered mental status, 
shortness of breath, and abdominal pain. A CT scan of 
her chest showed a left lower lobe inﬁ  ltrate and bilateral 
pleural effusions. An ultrasound examination of the right 
upper quadrant showed no abnormalities. She was trans-
ferred to the 10th CSH in Baghdad for further care. She 
remained febrile (39.8°C) and tachycardic and required 4 
L/min of oxygen via nasal cannula to maintain an oxygen 
saturation of 96%. Results of laboratory tests conducted 
at the time of admission were unremarkable except for 
a mild transaminitis (AST 139 and ALT 96). She was 
treated with levoﬂ  oxacin, 500 mg per day intravenously, 
for suspected pneumonia. She had rapid worsening of her 
respiratory status over the next 8 hours and required intu-
bation. Antimicrobial drug coverage was broadened to in-
clude piperacillin/tazobactam 3.375 parenterally every 6 
hours; solumedrol was added, given her history of asthma. 
She was evacuated to Landstuhl Regional Medical Center 
in Germany. A bronchoscopy was performed, but results 
were unremarkable. Her chest radiographs showed pro-
gression to acute respiratory distress syndrome (ARDS), 
and arterial blood gas testing showed partial pressure of 
arterial oxygen to be 50–60 mm Hg. Blood, sputum, and 
urine cultures were negative. Doxycycline was prescribed 
for possible Q fever. She improved and was evacuated 
to WRAMC, where she was afebrile (37.2°C) at admis-
sion. Her pulmonary status improved quickly, and she 
was extubated. She was discharged and completed 14-day 
courses of levoﬂ  oxacin and doxycycline. Her serologic 
test results were positive for Q fever with phase 2 IgM 
titer of 1,024. No exposure risks were identiﬁ  ed.
Conclusions
Fever, pneumonia, and/or hepatitis are the most com-
mon signs of acute infection with Q fever (4,5). In those in 
whom chronic disease develops, infective endocarditis is 
the initial condition in >70% of cases. Asymptomatic infec-
tion may occur in >50% of infected patients (4,5). Despite 
its typical signs and symptoms, Q fever is known to have 
a multitude of clinical manifestations. Raoult described 
>7 distinct presentations (6): fever, pneumonia, hepatitis, 
meningitis, meningoencephalitis, pericarditis, and myocar-
ditis. Parker et al. described >30 clinical syndromes (4). 
This broad variation can result in delayed diagnosis. 
Only 12 cases of acute cholecystitis associated with Q 
fever have been reported in the English medical literature 
(7–10). The largest and most detailed description is from a 
case series by Rolain (7), who described 9 patients whose 
initial sign of Q fever was acute cholecystitis. Clinical data 
are available for only 1 other case (8). The most appropriate 
treatment for these patients remains a question. For these 10 
patients, 6 had cholecystectomy. The remaining 4 and our 2 
patients did well with medical management alone. Four of 
the 6 patients received doxycycline, 1 received oﬂ  oxacin, 
and 1 received no treatment. Q fever is often self-limiting; 
yet treatment is recommended to shorten duration of symp-
toms and prevent chronic disease (5).
Reina-Serrano recently suggested that patients with 
Q fever–associated cholecystitis could be managed medi-
cally (8). Two of our patients had evidence of cholecystitis 
on imaging studies but did not have evidence of peritonitis 
on physical examination. Our 2 patients with radiographic 
cholecystitis responded quickly to doxycycline. We pro-
pose that for patients with acute acalculous cholecystitis 
and a high suspicion for Q fever, doxycycline be given em-
pirically. The patients’ clinical response should be evident 
within 48 hours and surgery may be avoided. If a patient has 
gallstones or acute abdominal pain, a standard approach for 
treating acute cholecystitis should be followed.
The third patient in our series progressed to ARDS, 
which has been reported, albeit rarely, with Q fever 
(1,4,11,12). More typically, pneumonia secondary to acute 
Q fever infection results in a dry to productive cough, pleu-
ritic chest pain, and focal or bilateral inﬁ  ltrates on chest 
radiographs (6). 
Our patients denied having typical risk factors, includ-
ing exposure to livestock or consumption of local meat or 
dairy products. However, direct exposure to such prod-
ucts is not necessary (1,4,5). We agree with Anderson et 
al., who suggested that providers strongly consider adding 
Figure. Computed tomographic scans of 
abdomens of 2 patients with inﬂ  ammation 
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doxycycline to the treatment regimen for deployed soldiers 
with severe pneumonia (1).
Q fever is a Category B biologic agent and must be 
considered as a potential threat to deployed soldiers (13). 
The most likely mode of attack would be aerosolization; 
given the low dose required for infection (1–10 organisms), 
multiple cases would follow. We considered bioterrorism 
unlikely, given the limited number of clinically symptom-
atic cases and the lack of a cluster of cases.
Q fever continues to be a threat to deployed US sol-
diers in Southwest Asia. Lack of knowledge about it can 
delay diagnosis and treatment. It should be considered in 
the differential diagnosis of any deployed or recently de-
ployed soldier with a febrile illness, especially when hepa-
titis or pneumonia is present. 
Dr Hartzell is an infectious disease fellow at WRAMC in 
Washington, DC, and an assistant professor of medicine at the 
Uniformed Services University in Bethesda, Maryland. His re-
search is focused on leishmaniasis and HIV.
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